European Journal of Inorganic Chemistry · 2003 · 55 citations · 34 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyChemotherapyMolecular OncologyCytotoxic ChemotherapyDisulfide Bond FormationGlutathione ConjugationDisulfide Bond ChemistryDisulfide ChemistryGlutathione Redox SystemGlutathione SystemGlutathione-dependent Disulfide FormationPlatinum-based Agents
Abstract Reactions of [Pt( rac ‐1,2‐DACH)Cl 2 ], [Pt(1 R ,2 R ‐DACH)Cl 2 ] and the anticancer drug oxaliplatin with the tripeptide glutathione and glutathione disulfide have been studied by HPLC, ESI‐MS and NMR methods. The same two major products are formed in each reaction: a thiolate‐bridged dimer and a novel thiolate‐bridged dinuclear macrochelate containing a nine‐membered chelate ring. Redox reactions of Pt II anticancer drugs with biological disulfides are of potential importance to their mechanism of action. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
34
Olivier Rixe, Waldo Ortuzar, Manuel Álvarez et al. · Biochemical Pharmacology · 1996 · 615 citations
Medicine, Oncology, Pharmacology +15
Clinical pharmacokinetics of oxaliplatin: a critical review.
Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 461 citations